Hedia announced this week it has raised €3 million in a seed extension round strongly supported by existing shareholders and Business Angels.

Hedia本周宣布，在现有股东和商业天使的大力支持下，它已经在种子期延长回合中筹集了300万欧元。

The new capital will enable Hedia's growth strategy and promising digital health product roadmap, continue to scale their Hedia Diabetes Assistant (HDA), as well as launching the Glooko- integrated holistic diabetes management solution later in the year.  Furthermore, the company will leverage its competencies in developing smart AI-enabled algorithms and Software-as-a-Medical Device (SaMD) solutions together with strategic partners within chronic metabolic diseases..

新首都将实现Hedia的增长战略和有前景的数字健康产品路线图，继续扩大Hedia Diabetes Assistant（HDA）的规模，并在今年晚些时候推出Glooko综合整体糖尿病管理解决方案。此外，该公司将利用其能力，与慢性代谢疾病领域的战略合作伙伴一起开发智能人工智能算法和软件即医疗设备（SaMD）解决方案。

This exciting news follows the update earlier this week, where Hedia announced their new CEO, Lars Lund.

这一令人兴奋的消息是在本周早些时候Hedia宣布其新任CEO Lars Lund的最新消息之后发布的。

Today, Lars Christian Lund said about the financial extension, 'As I take the reins in Hedia, I am delighted to see the confidence from our investors in our world class team, our existing groundbreaking technology as well as our strong pipeline.  Hedia will now be able to build on our existing momentum and accelerate the commercialization of our solutions making life with diabetes easier.'.

今天，拉尔斯·克里斯蒂安·隆德（LarsChristianLund）谈到了此次财务延期，“当我执掌Hedia时，我很高兴看到我们的投资者对我们的世界级团队、我们现有的突破性技术以及我们强大的渠道充满信心。Hedia现在将能够利用我们现有的势头，加速我们解决方案的商业化，使糖尿病患者的生活更加轻松。”

About Hedia

关于Hedia

Hedia is a leading digital therapeutics company within diabetes, committed to help people with insulin-dependent diabetes gain control of their condition.  Making life with diabetes easier has been the incentive from the beginning of building Hedia Diabetes Assistant and the solution is today available in 11 countries.

Hedia是糖尿病领域领先的数字治疗公司，致力于帮助胰岛素依赖型糖尿病患者控制病情。从建立Hedia diabetes Assistant开始，让糖尿病患者的生活变得更加轻松一直是激励因素，目前该解决方案已在11个国家推出。

Based on habits of the individual person with diabetes and personalized input, our diabetes app generates insulin recommendations by taking many aspects of diabetes management into account – such as recording blood glucose readings, keeping track of active insulin, measuring carbs, calculating an insulin dosage, keeping track of activity and recording blood ketones..

根据糖尿病患者的习惯和个性化输入，我们的糖尿病应用程序通过考虑糖尿病管理的许多方面来生成胰岛素建议，例如记录血糖读数，跟踪活性胰岛素，测量碳水化合物，计算胰岛素剂量，跟踪活动和记录血液酮。